Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Triangle (HCTI) Receivables (2020 - 2025)

Historic Receivables for Healthcare Triangle (HCTI) over the last 6 years, with Q3 2025 value amounting to $6.1 million.

  • Healthcare Triangle's Receivables rose 15826.64% to $6.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.1 million, marking a year-over-year increase of 15826.64%. This contributed to the annual value of $1.4 million for FY2024, which is 6324.7% down from last year.
  • Per Healthcare Triangle's latest filing, its Receivables stood at $6.1 million for Q3 2025, which was up 15826.64% from $5.2 million recorded in Q2 2025.
  • Healthcare Triangle's 5-year Receivables high stood at $10.5 million for Q4 2021, and its period low was $1.6 million during Q1 2025.
  • In the last 5 years, Healthcare Triangle's Receivables had a median value of $5.2 million in 2023 and averaged $5.2 million.
  • In the last 5 years, Healthcare Triangle's Receivables tumbled by 6139.33% in 2024 and then surged by 15826.64% in 2025.
  • Quarter analysis of 5 years shows Healthcare Triangle's Receivables stood at $10.5 million in 2021, then tumbled by 33.83% to $6.9 million in 2022, then tumbled by 48.0% to $3.6 million in 2023, then crashed by 50.35% to $1.8 million in 2024, then soared by 240.85% to $6.1 million in 2025.
  • Its Receivables stands at $6.1 million for Q3 2025, versus $5.2 million for Q2 2025 and $1.6 million for Q1 2025.